| Literature DB >> 26141137 |
Anthony Chauvin1,2, Philippe Ravaud3,4,5, Gabriel Baron6,7, Caroline Barnes8,9, Isabelle Boutron10,11,12.
Abstract
BACKGROUND: The peer review process is a cornerstone of biomedical research publications. However, it may fail to allow the publication of high-quality articles. We aimed to identify and sort, according to their importance, all tasks that are expected from peer reviewers when evaluating a manuscript reporting the results of a randomized controlled trial (RCT) and to determine which of these tasks are clearly requested by editors in their recommendations to peer reviewers.Entities:
Mesh:
Year: 2015 PMID: 26141137 PMCID: PMC4491236 DOI: 10.1186/s12916-015-0395-3
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Fig. 1Flow chart of the survey of tasks expected of peer reviewers
Thirty-six tasks created for the Q-sort survey
| Etiquette objectives | To read the journals’ recommendations to reviewers |
| To provide recommendations on publication (e.g., reject/revise/publish) | |
| To evaluate all appendices when available | |
| Rationale | To evaluate the novelty of the study (i.e., does the trial add enough to what is already in the published literature) |
| To evaluate the importance of the study (i.e., usefulness for clinical practice) | |
| Methods | To evaluate if the control group is appropriate |
| To evaluate the risk of bias of the trial | |
| To evaluate the adequacy of the selection of participants and clinical setting | |
| To check if the intervention is described with enough details to allow replication | |
| To evaluate the relevance of the primary outcome(s) | |
| To evaluate the reliability and validity of the outcome measures | |
| Trial registration | To compare information recorded on a clinical trials register such as ClinicalTrials.gov and reported in the manuscript |
| To compare information recorded in the trial protocol when provided by the authors and reported in the manuscript | |
| Reporting guidelines | To check if the items requested by the CONSORT statement are adequately reported by authors |
| To check if items requested by the CONSORT extensions (e.g., cluster, non-pharmacologic treatments etc.) are adequately reported when appropriate | |
| Ethic | To check if the study reported ethics review board approval |
| Statistics | To evaluate the adequacy of statistical analyses |
| To check the sample size calculation | |
| Results | To search for any inconsistencies or errors in the manuscript |
| To search for any attempt to distort the presentation or interpretation of results (e.g., data “beautification”, spin, selective reporting) | |
| To check if all outcomes are adequately reported (results for each group, and the estimated effect size and its precision such as 95 % confidence interval) | |
| To check if all adverse events are adequately reported (participant withdrawals due to harms, absolute risk per arm and per adverse event type, grade, and seriousness) | |
| Discussion | To evaluate if the discussion is consistent with the results |
| To check if the authors referenced all important studies | |
| To check that limitations are adequately reported | |
| To discuss the results in relation to other studies | |
| Conclusion | To determine whether the manuscript conclusion is consistent with the results |
| Fraud | To search for plagiarism or imitation in the paper |
| To evaluate if the manuscript can be suspected of fraud | |
| Figures tables | To check if all figures and tables are consistent with the text |
| To evaluate whether figures and tables can be understood without having to refer the text | |
| References | To evaluate if authors respect the requested format for references |
| Presentation | To evaluate the adequacy of the language (grammar, style, misspelling) |
| To evaluate clarity of presentation | |
| Abstract | To check if the authors reported all important outcomes and adverse events in the abstract |
| To evaluate if the abstract conclusion is consistent with the results |
Participant characteristics
| Characteristic | Total |
|---|---|
| N = 203 | |
| Expertise | N (%) |
| − Clinician | 93 (45.8) |
| − Methodologist | 72 (35.5) |
| − Both (clinician/methodologist) | 17 (8.4) |
| − Other | 21 (10.3) |
| Affiliationa | |
| − Non-profit | 179 (95.7) |
| − For-profit | 5 (2.7) |
| − Publisher | 3 (1.6) |
| Countryb | |
| − Oceania | 14 (8.9) |
| − South America/Asia | 15 (9.6) |
| − USA/Canada | 51 (32.5) |
| − Europe | 77 (49.0) |
| Total no. of completed randomized trials participated in as an investigatorc | |
| −0 | 17 (8.4) |
| −1–5 | 99 (48.8) |
| −6–10 | 42 (20.7) |
| −11–15 | 19 (9.4) |
| −16–20 | 4 (2.0) |
| − >20 | 22 (10.8) |
| Mean no. of articles peer-reviewed per yearc | |
| −1–5 | 35 (17.2) |
| −6–10 | 51 (25.1) |
| −11–20 | 55 (27.1) |
| −20–50 | 39 (19.2) |
| − >50 | 23 (11.3) |
| Mean no. of articles reporting an RCT peer-reviewed per yearc | |
| −1–5 | 150 (73.9) |
| −6–10 | 27 (13.3) |
| −11–20 | 13 (6.4) |
| −20–50 | 8 (3.9) |
| − >50 | 5 (2.5) |
| Ask colleagues to help with the peer reviewc | |
| − Never | 58 (28.6) |
| − Rarely | 92 (45.3) |
| − Sometimes | 41 (20.2) |
| − Regularly | 10 (4.9) |
| − Always | 2 (1.0) |
| Trainingd | |
| − Formal academic training | 33 (16.4) |
| − Mentoring by your supervisor | 59 (29.4) |
| − Tutorial on training sessions offered by editors | 13 (6.5) |
| − Not trained | 61 (30.3) |
| − Other trained | 2 (1.0) |
| − Several forms of training | 33 (16.4) |
| Mean time for a peer review of an RCT (hours)c | |
| − <1 | 7 (3.4) |
| −1–2 | 72 (35.5) |
| −2–4 | 85 (41.9) |
| − >4 | 39 (19.2) |
| Agree to disclose your name when proposed or requested by an editorc | |
| − Never | 25 (12.3) |
| − Rarely | 25 (12.3) |
| − Sometimes | 49 (24.1) |
| − Regularly | 45 (22.2) |
| − Always | 59 (29.1) |
a12 (5.9 %) missing data; b46 (22.7 %) missing data; cNo missing data; d2 (1 %) missing data
RCT Randomized controlled trial
Tasks sorted by participants in the Q-sort survey. Data are (overall rank) and mean ± SD rank of participants
| Total | Clinician | Methodologist | Both | Other | |
|---|---|---|---|---|---|
| (N = 203) | (N = 93) | (N = 72) | (N = 17) | (N = 21) | |
| To evaluate the risk of bias of the trial |
|
|
|
|
|
| To determine if the manuscript conclusion is consistent with the results |
|
|
|
|
|
| To evaluate the adequacy of statistical analyses |
|
|
|
|
|
| To evaluate if the control group is appropriate |
|
|
|
|
|
| To check if all outcomes are adequately reported |
|
|
|
|
|
| To evaluate the relevance of the primary outcome(s) |
|
|
|
|
|
| To search for any attempt to distort the presentation or interpretation of results |
|
|
|
|
|
| To evaluate the reliability and validity of the outcome measures |
|
|
|
|
|
| To evaluate the importance of the study |
|
|
|
|
|
| To evaluate if the abstract conclusion is consistent with the results |
|
|
|
|
|
| To evaluate if the discussion is consistent with the results |
|
|
|
|
|
| To check if all adverse events are adequately reported |
|
|
|
|
|
| To check if the intervention is described with enough details to allow replication |
|
|
|
|
|
| To check that limitations are adequately reported |
|
|
|
|
|
| To evaluate the adequacy of the selection of participants and clinical setting |
|
|
|
|
|
| To search for any inconsistencies or errors in the manuscript |
|
|
|
|
|
| To evaluate the novelty of the study |
|
|
|
|
|
| To check the sample size calculation |
|
|
|
|
|
| To check if the authors reported all important outcomes and adverse events in the abstract |
|
|
|
|
|
| To discuss the results in relation to other studies |
|
|
|
|
|
| To evaluate if the manuscript can be suspected of fraud |
|
|
|
|
|
| To provide recommendations on publication |
|
|
|
|
|
| To check if all figures and tables are consistent with the text |
|
|
|
|
|
| To evaluate clarity of presentation |
|
|
|
|
|
| To check if the study reported ethics review board approval |
|
|
|
|
|
| To search for plagiarism or imitation in the paper |
|
|
|
|
|
| To compare information recorded in the trial protocol when provided by the authors and reported in the manuscript |
|
|
|
|
|
| To check if the items requested by the CONSORT Statement are adequately reported by authors |
|
|
|
|
|
| To check if the authors referenced all important studies |
|
|
|
|
|
| To evaluate whether figures and tables can be understood without having to refer the text |
|
|
|
|
|
| To check if items requested by the CONSORT extensions are adequately reported when appropriate |
|
|
|
|
|
| To compare information recorded on a clinical trials register such as ClinicalTrials.gov and reported in the manuscript |
|
|
|
|
|
| To read the journals’ recommendations to reviewers |
|
|
|
|
|
| To evaluate all appendices when available |
|
|
|
|
|
| To evaluate the adequacy of the language |
|
|
|
|
|
| To evaluate if authors respect the requested format for references |
|
|
|
|
|
Fig. 2Representation for each task of the proportion of participants rating the task in the first tertile (i.e., ≥2 on the scale from −5 to +5 for each task) and the proportion of editors requesting the task in their recommendations to authors. The tasks are sorted according to the mean ranking of participants